MedTrace Logo

Waist Circumference Measurements in Schizophrenic Patients

NCT01243034 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2019-02-01

No results posted yet for this study

Summary

The prevalence of metabolic syndrome(MS) among pt's with schizophrenia has been reported to be high, ranging from 24 to 43% in males and 27 to 52% in females. Schizophrenic patients with MS have an increased incidence of DM, coronary heart disease and increased mortality from cardiovascular diseases. Central adiposity is highly correlated with the presence of hypertension, coronary heart disease, type 2 diabetes, and increased mortality risk. Waist circumference(WC) is a better indicator of abdominal obesity and a better predictor of CVD than either BMI or waist-to-hip ratio. However, currently there is no standard location for the measurement of WC.

Objectives: 1. To compare the magnitude of WC measured at 3 sites ( immediately above the iliac crest, midpoint between the lowest rib and the iliac crest , umbilical level) in males and females.

2\. To examine the correlation of WC with Triglyceride, cholesterol, HDL, LDL and glucose.

Conditions

  • Waist Circumference Measurements
  • Schizophrenia
  • Cardiovascular Risk Factor

Sponsors & Collaborators

  • Changhua Christian Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-01
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01243034 on ClinicalTrials.gov